AR and hepatocellular carcinoma: Studies have reported higher androgen levels and more active androgen receptor alleles in male HBV carriers, particularly in high-risk populations for HCC.[20] Androgens enhance HBV gene replication and transcription by binding directly to the androgen response element in the enhancer I of the HBV genome, resulting in a synergistic oncogenic effect with HBV.